BALLERUP, Denmark and SHANGHAI, China – LiqTech Worldwide, Inc. (NASDAQ: NASDAQ:), a supplier of superior filtration applied sciences, has entered right into a Memorandum of Understanding (MoU) with China Haisum Engineering Co., Ltd. to discover industrial water therapy options in China.
This collaboration goals to implement LiqTech’s silicon carbide membrane-based ultrafiltration expertise throughout varied industries in China, addressing the growing demand for environmental safety and sustainability.
China Haisum Engineering, listed as Inventory Code 002116, is a complete engineering firm providing providers in a number of sectors together with mild trade, agriculture, and public utilities.
The partnership with LiqTech aligns with China Haisum’s dedication to technological innovation and sustainable growth. Normal Supervisor Wen Zheng expressed anticipation for the joint efforts to advance this expertise in mild trade and different fields.
LiqTech’s CEO Fei Chen highlighted China’s significance as a marketplace for industrial water therapy, and the corporate’s ultrafiltration expertise has proven promising outcomes globally. This MoU is predicted to facilitate the introduction of LiqTech’s superior membrane filtration expertise into the Chinese language market, the place China Haisum offers engineering providers.
LiqTech Worldwide focuses on ceramic silicon carbide filtration applied sciences for gasoline and liquid purification, together with controlling diesel exhaust soot emissions.
InvestingPro Insights
As LiqTech Worldwide, Inc. (NASDAQ: LIQT) forges a strategic partnership with China Haisum Engineering Co., Ltd. (Inventory Code 002116) to ship industrial water therapy options in China, a more in-depth have a look at China Haisum’s monetary metrics offers a clearer image of the corporate’s market place. With a stable market capitalization of $560.25 million, China Haisum showcases a steady funding profile. The corporate’s P/E ratio, a measure of its present share value relative to its per-share earnings, stands at 12.44, indicating an affordable valuation in comparison with trade friends. Adjusted for the final twelve months as of Q1 2024, the P/E ratio experiences a slight enhance to 13.74.
Traders in search of progress potential in a inventory will discover China Haisum’s PEG ratio of 0.35 notably engaging, suggesting that the inventory could also be undervalued given its earnings progress prospects. That is additional corroborated by a powerful income progress of 14.63% throughout the identical interval. The corporate’s dedication to innovation and sustainable growth aligns with its monetary progress, as evidenced by a considerable EBITDA progress of 78.8% within the final twelve months as of Q1 2024.
For these desirous about dividend returns, China Haisum’s dividend yield stands at 2.95%, with a notable dividend progress of 82.62% within the final twelve months as of Q1 2024. This displays the corporate’s potential to generate adequate earnings to help dividend payouts, which is a beautiful function for income-focused traders.
InvestingPro Suggestions spotlight extra strategic facets of China Haisum’s monetary well being. For example, the corporate’s sturdy income and EBITDA progress charges emphasize its operational effectivity and profitability potential. For extra complete evaluation and insights, InvestingPro features a whole of 15 extra suggestions for traders contemplating including China Haisum to their portfolio.
General, these monetary metrics and InvestingPro Suggestions underscore the potential of China Haisum’s collaboration with LiqTech Worldwide, suggesting a promising avenue for progress and shareholder worth within the burgeoning subject of environmental sustainability and industrial water therapy in China.
This text was generated with the help of AI and reviewed by an editor. For extra data see our T&C.
